Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01524835 · ClinicalTrials.gov registry record

Live Lung Donor Cross-sectional Cohort Study

A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

Completed
Registry status
192
Enrollment target

NCT01524835: Completed study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

NCT01524835 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 192 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01524835 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

COMPLETED
Registry status
192 participants
Enrollment target

Study Summary

This study will gather information on the long-term effects of donating a lung lobe on living donors.

Trial Details

FieldValue
Enrollment Target 192 participants
Start Date 2010-08
Est. Completion 2012-10

What the finished NCT01524835 record still lists

NCT01524835 is an observational study that tracks outcomes without assigning an intervention. The registered 192 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT01524835 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01524835 about?

NCT01524835 is a clinical study titled "Live Lung Donor Cross-sectional Cohort Study". This study will gather information on the long-term effects of donating a lung lobe on living donors.

What is the current status of trial NCT01524835?

This trial is currently completed. The enrollment target is 192 participants. The study started on 2010-08. Estimated completion is 2012-10.

Who is sponsoring clinical trial NCT01524835?

This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01492972 · 192 participants · Phase 3

    Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer

  • NCT01973881 · 192 participants

    Quantitative MRI for Myelofibrosis

  • NCT02535702 · 192 participants · NA

    Development Of Neuroimaging Methods To Assess The Neurobiology Of Addiction

  • NCT03622359 · 192 participants · NA

    Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01524835, the US trial registry maintained by the National Library of Medicine. NCT01524835 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.